Bristol-Myers Squibb UK has moved into a new state-of-the-art head office in Uxbridge.The £5.5 million building houses over 200 employees, …
Merck Pharmaceuticals has engaged Medicom to improve compliance in diabetic patients as part of the communications strategy for its type …
Sanofi-Aventis is gearing up for the launch of its potential blockbuster Acomplia, a drug which the company wants to promote …
Bernhard Scheuble has stepped down as chief executive of German pharma company Merck KGaA, disagreements with the company's owners thought …
The number of people living with HIV in the UK is now more than 58,000 – including nearly 20,000 who …
GlaxoSmithKline has released new data on a number of promising new drugs in its oncology pipeline – including breast cancer …
Two of European pharma's mid-sized companies, Serono and Altana, have separately declared their openness to takeover talks, with Pfizer and …
More than three million extra patients could be prescribed statins in England and Wales in response to new guidance – …
Smokers taking a new Pfizer treatment are more likely to kick the habit compared to those using GlaxoSmithKline's Zyban, according …
Nine out of ten European pharmaceutical companies believe they need to make significant changes to their businesses as a result …
AstraZeneca has filed a lawsuit in the US courts to block the launch of a generic version of Nexium.The ulcer …
Take part in Pharmafocus' industry poll on the leading product pipelinesThe pharma industry has experienced another turbulent year of change …
Chiron has agreed to help the UK government make up a shortfall in flu vaccine supplies by producing an extra …
A new survey of the UK pharmaceutical industry has found PR is considered just as important to marketing efforts as …
The FDA says there is no evidence that Tamiflu was linked to the death of 12 children taking the antiviral …
Roche has released new phase II data for a highly promising new anaemia treatment – but Amgen are determined to …
Two UK biotech companies say their innovative antibody drug could be a breakthrough in treating the chronic respiratory disease COPD.Chronic …
Sales of GlaxoSmithKline's number one product asthma drug Advair could be hit by new safety warnings imposed by the US …
The University of Oxford and GlaxoSmithKline are to work together with researchers in India to set up the country's first …
Pharmaceutical executives are voting in their hundreds every week in a unique survey to find out which companies are the …